Trials / Not Yet Recruiting
Not Yet RecruitingNCT07105956
Radiolabeled TSPO Targeted Molecular Probe in Alzheimer's Disease.
Clinical Application of a Novel Radiolabeled Translocator Protein (TSPO) Targeted Small Molecular Probe in Neuroinflammation Imaging of Alzheimer's Disease.
- Status
- Not Yet Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 8 (estimated)
- Sponsor
- Nanjing First Hospital, Nanjing Medical University · Academic / Other
- Sex
- All
- Age
- 18 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
Evaluate the clinical application value of the novel radiolabeled TSPO-targeted molecular probe Gallium \[68Ga\]-DOTA-HK-011 in neuroinflammation imaging of Alzheimer's disease.
Conditions
Timeline
- Start date
- 2025-09-01
- Primary completion
- 2026-08-31
- Completion
- 2026-08-31
- First posted
- 2025-08-06
- Last updated
- 2025-08-06
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT07105956. Inclusion in this directory is not an endorsement.